Cas:75942-37-9 3,6-dibutoxybenzene-1,2-dicarbonitrile manufacturer & supplier

Chemical Name:3,6-dibutoxybenzene-1,2-dicarbonitrile

CAS.NO:75942-37-9

Synonyms:1,4-dibutoxy-2,3-dicyanobenzene;2,5-dibutoxyphtalonitrile;3,6-Dibutoxyphthalonitrile;3,6-dibutoxy-1,2-benzenedicarbonitrile;MFCD00134586

Molecular Formula:C₁₆H₂₀N₂O₂

Molecular Weight:272.34200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:447.4ºC at 760 mmHg

Density:1.07g/cm3

Index of Refraction:1.516

PSA:66.04000

Exact Mass:272.15200

LogP:3.78776

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 1,4-dibutoxy-2,3-dicyanobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00134586 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4-dibutoxy-2,3-dicyanobenzene Use and application,MFCD00134586 technical grade,usp/ep/jp grade.

Related News: At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances. 3,6-dibutoxybenzene-1,2-dicarbonitrile manufacturer First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory. 3,6-dibutoxybenzene-1,2-dicarbonitrile supplier Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed. 3,6-dibutoxybenzene-1,2-dicarbonitrile vendor Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. 3,6-dibutoxybenzene-1,2-dicarbonitrile factory At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.